Skip to main content

Table 1 Description and comparison of socio-demographic and clinical characteristics by living arrangements

From: Associations of living arrangements with symptoms and functioning in schizophrenia

Variables

Mean (SD) or n (%)

Comparisons

All

Spouse/ Partner

Family

Independent

Rehabilitation

Living arrangements

276 (100%)

33 (11.96%)

185 (67.03%)

17 (6.16%)

41 (14.86%)

 

Housing

χ2(9) = 312.207, p < 0.001

 Private

15 (5.43%)

3 (9.09%)

12 (6.49%)

–

–

 

 Public

180 (65.22%)

24 (72.73%)

150 (81.08%)

6 (35.29%)

–

 

 Rental

40 (14.49%)

6 (18.18%)

23 (12.43%)

11 (64.71%)

–

 

 Rehabilitation centres

41 (14.86%)

–

–

–

41 (100%)

 

Sex (Male)

152 (55.07%)

14 (42.42%)

105 (56.76%)

10 (58.82%)

23 (56.10%)

χ2(3) = 2.460, p = 0.483

Age, years

40.42 (10.14)

45.85 (8.19)

38.38 (9.76)

46.71 (8.38)

42.66 (11.01)

F(3, 272) = 9.267, p < 0.001

 20–29

46 (16.67%)

0 (0.00%)

38 (82.61%)

0 (0%)

8 (17.39%)

χ2(12) = 27.805, p = 0.006

 30–39

86 (31.16%)

7 (8.14%)

67 (77.91%)

3 (3.49%)

9 (10.47%)

 

 40–49

83 (30.07%)

15 (18.07%)

49 (59.04%)

7 (8.43%)

12 (14.46%)

 

 50–59

53 (19.20%)

9 (16.98%)

28 (52.83%)

6 (11.32%)

10 (18.87%)

 

    60–69

8 (2.90%)

2 (25.00%)

3 (37.50%)

1 (12.50%)

2 (25.00%)

 

Age of onset of illness, years

23.11 (6.50)

25.79 (7.82)

22.29 (6.10)

23.06 (4.62)

24.66 (7.06)

H(3) = 8.481, p = 0.037

Ethnicity1

χ2(6) = 11.258, p = 0.081

 Chinese

233 (84.73%)

28 (12.02%)

163 (69.96%)

13 (5.58%)

29 (12.45%)

 

 Malay

20 (7.27%)

3 (15.00%)

10 (50.00%)

1 (5.00%)

6 (30.00%)

 

 Indian

22 (8.00%)

1 (4.55%)

12 (54.55%)

3 (13.64%)

6 (27.27%)

 

Education, years

13.17 (3.12)

13.05 (3.43)

13.41 (3.01)

13.02 (3.22)

12.23 (3.21)

F(3, 272) = 1.636, p = 0.181

Smoking status2

χ2(6) = 9.569, p = 0.144

 Current smoker

60 (21.98%)

4 (12.12%)

37 (20.22%)

8 (47.06%)

11 (27.50%)

χ2(3) = 9.148, p = 0.027 4

 Ex-smoker

36 (13.19%)

5 (15.15%)

26 (14.21%)

1 (5.88%)

4 (10.00%)

 

 Non-smoker

177 (64.84%)

24 (72.73%)

120 (65.57%)

8 (47.06%)

25 (62.50%)

 

Employed

127 (46.01%)

19 (57.58%)

91 (49.19%)

6 (35.29%)

11 (26.83%)

χ2(3) = 9.388, p  = 0.025

Physical comorbidity

178 (64.49%)

23 (69.70%)

113 (61.08%)

14 (82.35%)

28 (68.29%)

χ2(3) = 3.957, p = 0.266

Antipsychotic dose*, mg

461.67 (406.25)

314.78 (305.71)

453.95 (400.13)

603.35 (574.38)

556.02 (394.61)

H(3) = 11.856, p = 0.008

Illness exacerbation

2.98 (1.48)

2.45 (1.15)

2.91 (1.49)

3.76 (1.64)

3.39 (1.37)

H(3) = 12.636, p = 0.005

SOFAS

55.51 (11.20)

63.61 (12.56)

54.89 (11.31)

51.00 (9.46)

53.95 (7.25)

Brown-Forsythe F(3, 74.752) = 7.390, p < 0.001

PANSS Total

58.11 (12.88)

50.41 (11.11)

59.08 (13.14)

61.59 (13.83)

58.32 (10.62)

H(3) = 14.457, p = 0.002

PANSS Positive

8.31 (4.35)

6.13 (3.02)

8.46 (4.43)

9.88 (4.73)

8.66 (4.28)

H(3) = 11.630, p = 0.009

PANSS Negative

11.28 (4.05)

9.31 (3.11)

11.66 (4.02)

11.35 (4.26)

11.12 (4.42)

H(3) = 9.412, p = 0.024

PANSS Excitement

4.60 (2.06)

4.31 (1.91)

4.73 (2.14)

4.82 (2.24)

4.15 (1.65)

H(3) = 2.625, p = 0.453

PANSS Depression

5.60 (2.50)

4.97 (2.09)

5.69 (2.56)

6.29 (3.08)

5.41 (2.21)

H(3) = 2.693, p = 0.441

PANSS Cognition

4.34 (1.64)

3.81 (1.55)

4.40 (1.67)

4.18 (1.38)

4.54 (1.66)

H(3) = 4.341, p = 0.227

Symptomatic remission3

76 (27.74%)

17 (53.13%)

49 (26.63%)

3 (17.65%)

7 (17.07%)

χ2(3) = 13.592, p = 0.004

  1. *Antipsychotic doses were converted into total daily chlorpromazine equivalents
  2. 1 Valid percentages were presented; 1 individual with other ethnicity living with spouse excluded
  3. 2 Valid percentages were presented; 2 missing data observed in people living with parents, 1 missing data in people living in rehabilitation centres
  4. 3 Valid percentages were presented; 1 missing data observed in people living with spouse, 1 missing data in people living with family
  5. 4 Association between current smoker vs. ex-smoker/non-smoker and 4 types of living arrangements
  6. SOFAS, Social and Occupational Functioning Scale; PANSS, Positive and Negative Syndrome Scale